Intellectual Property India Publishes Patent Application for 'Crispr-Mediated Gene Editing To Induce Fetal Hemoglobin' Filed by Micro Crispr Pvt. Ltd.

MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202421004086 A) filed by Micro Crispr Pvt. Ltd., Vapi, Gujarat, on Feb. 19, 2024, for 'crispr-mediated gene editing to induce fetal hemoglobin.'

Inventor(s) include Bhargava, Nupur; Vyas, Jitendra; and Bilakhia, Aaman.

The application for the patent was published on Sept. 5, under issue no. 36/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure discloses a gene editing system (100) to induce expression of fetal hemoglobin (HbF) in hematopoietic stem cells (HSCs). The gene editing system (100) includes a guide RNA (gRNA 110) extending between a 5'end and a 3' end, and an endonuclease (120). The gRNA (1...